Skip to main content

Raquel C. Bono, M.D., M.B.A., FACS

Equibles does not estimate personal net worth.

About Raquel C. Bono, M.D., M.B.A., FACS

Raquel C. Bono, M.D., M.B.A., FACS is recorded as Board Member at Vaxart, Inc. (VXRT) since October 16, 2026. Vaxart, Inc. reported in an 8-K filed October 19, 2026 that Raquel C. Bono, M.D., M.B.A., FACS was appointed member of the Board, effective October 16, 2026. Vaxart, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Vaxart, Inc. includes Andrei Floroiu (CEO), Michael Finney (CEO), Michael J. Finney (CEO and Board Member) and 7 others.

“On October 16, 2026, following a recommendation by the Nominating and Governance Committee of the Board of Directors (the “Board”) of Vaxart, Inc. (the “Company”), the Board appointed Raquel C. Bono, M.D., M.B.A., FACS, to serve on the Board, effective immediately, and until Dr. Bono’s successor is elected and qualified, or sooner in the event of her death, resignation, or removal.”
Vaxart, Inc. Form 8-K, filed October 19, 2026 · Read the filing

Affiliation history

Company network

Current role

Biotechnology · Healthcare

Board Member

2026-10-16–present

Leadership on record at Vaxart, Inc.

Recent activity